Clinical Trial Update: Erythropoietin for Management of Anemia Caused by Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update on erythropoietin for managing anemia caused by chemotherapy in patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Kosin University Gospel Hospital | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: COMPLETED